Perfluorohexyloctane in dry eye disease: A systematic review of its efficacy and safety as a novel therapeutic agent
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Perfluorohexyloctane in dry eye disease: A systematic review of its efficacy and safety as a novel therapeutic agent
Authors
Keywords
-
Journal
Ocular Surface
Volume 30, Issue -, Pages 254-262
Publisher
Elsevier BV
Online
2023-10-07
DOI
10.1016/j.jtos.2023.10.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients
- (2023) Lei Tian et al. JAMA Ophthalmology
- Will the Long-Named Perfluorohexyloctane Produce Long-lasting Improvements in Patients With Meibomian Gland Disease?
- (2023) Gerami D. Seitzman et al. JAMA Ophthalmology
- Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape
- (2023) John D. Sheppard et al. Ophthalmology and Therapy
- Validation of a Modified National Eye Institute Grading Scale for Corneal Fluorescein Staining
- (2023) Kenneth Sall et al. Clinical Ophthalmology
- NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study
- (2023) John D. Sheppard et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease
- (2022) Marc Labetoulle et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Water-Free Omega-3 Fatty Acid Eye Drop Formulation for the Treatment of Evaporative Dry Eye Disease: A Prospective, Multicenter Noninterventional Study
- (2022) Christina Jacobi et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- NOV03 for Dry Eye Disease Associated With Meibomian Gland Dysfunction: Results of the Randomized Phase 3 GOBI Study
- (2022) Joseph Tauber et al. OPHTHALMOLOGY
- The prevalence of dry eye in a very old population
- (2021) Mukharram M. Bikbov et al. ACTA OPHTHALMOLOGICA
- Ocular benzalkonium chloride exposure: problems and solutions
- (2021) Michael H. Goldstein et al. EYE
- Validation of the Arabic version of the Ocular Surface Disease Index Questionnaire
- (2021) May M. Bakkar et al. International Journal of Ophthalmology
- Deciphering the Action of Perfluorohexyloctane Eye Drops to Reduce Ocular Discomfort and Pain
- (2021) Miguel Delicado-Miralles et al. Frontiers in Medicine
- Influence of Perfluorohexyloctane Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease: A Randomized Controlled Clinical Trial
- (2020) Doreen Schmidl et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Interactions of Perfluorohexyloctane With Polyethylene and Polypropylene Pharmaceutical Packaging Materials
- (2020) Yana Znamenskaya Falk et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessments
- (2020) Luke A. McGuinness et al. Research Synthesis Methods
- A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease
- (2020) Joseph Tauber et al. CORNEA
- Proposed Algorithm for Management of Meibomian Gland Dysfunction Based on Noninvasive Meibography
- (2020) Reiko Arita et al. Journal of Clinical Medicine
- Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics
- (2019) Priyanka Agarwal et al. Ocular Surface
- Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional Study
- (2019) Philipp Eberwein et al. OPHTHALMIC RESEARCH
- Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease
- (2019) Akie Midorikawa-Inomata et al. BMJ Open
- Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs
- (2018) Priyanka Agarwal et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease
- (2017) Philipp Steven et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- TFOS DEWS II Report Executive Summary
- (2017) Jennifer P. Craig et al. Ocular Surface
- TFOS DEWS II iatrogenic report
- (2017) José Alvaro P. Gomes et al. Ocular Surface
- TFOS DEWS II Tear Film Report
- (2017) Mark D.P. Willcox et al. Ocular Surface
- TFOS DEWS II pathophysiology report
- (2017) Anthony J. Bron et al. Ocular Surface
- TFOS DEWS II Introduction
- (2017) J. Daniel Nelson et al. Ocular Surface
- TFOS DEWS II pain and sensation report
- (2017) Carlos Belmonte et al. Ocular Surface
- TFOS DEWS II Epidemiology Report
- (2017) Fiona Stapleton et al. Ocular Surface
- TFOS DEWS II Diagnostic Methodology report
- (2017) James S. Wolffsohn et al. Ocular Surface
- TFOS DEWS II Management and Therapy Report
- (2017) Lyndon Jones et al. Ocular Surface
- TFOS DEWS II Definition and Classification Report
- (2017) Jennifer P. Craig et al. Ocular Surface
- Lifitegrast for the Treatment of Dry Eye Disease
- (2017) Edward J. Holland et al. OPHTHALMOLOGY
- The Pathophysiology of Dry Eye Disease
- (2017) Stephen C. Pflugfelder et al. OPHTHALMOLOGY
- Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease
- (2016) Yeoun-Hee Kim et al. CORNEA
- Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A Prospective, Multicenter Noninterventional Study
- (2015) Philipp Steven et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Comparison of Two Questionnaires for Dry Eye Symptom Assessment
- (2015) Francisco Amparo et al. OPHTHALMOLOGY
- Role of Hyperosmolarity in the Pathogenesis and Management of Dry Eye Disease: Proceedings of the OCEAN Group Meeting
- (2013) Christophe Baudouin et al. Ocular Surface
- Reduced in vivo Ocular Surface Toxicity with Polyquad-Preserved Travoprost versus Benzalkonium-Preserved Travoprost or Latanoprost Ophthalmic Solutions
- (2012) Hong Liang et al. OPHTHALMIC RESEARCH
- Semifluorinated alkanes – A new class of excipients suitable for pulmonary drug delivery
- (2010) C. Tsagogiorgas et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Comparison of Corneal and Conjunctival Changes After Dosing of Travoprost Preserved With sofZia, Latanoprost With 0.02% Benzalkonium Chloride, and Preservative-free Artificial Tears
- (2009) Malik Y Kahook et al. CORNEA
- Quantitative analysis of conjunctival goblet cells after chronic application of topical drops
- (2008) Malik Y. Kahook et al. ADVANCES IN THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now